S
Sophia Genetics SA
NASDAQ:SOPH
Sophia Genetics SA
NASDAQ:SOPH
Price:
4.96 USD
-0.8%
Market Closed
Updated:
May 6, 2024
Section:
Relative Value
The Relative Value of one SOPH stock under the Base Case scenario is 6 USD. Compared to the current market price of 4.96 USD, Sophia Genetics SA is Undervalued by 17%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SOPH
Relative Value
Base Case
6
USD
Undervaluation 17%
S
Valuation Multiples
Multiples Across Competitors
SOPH Competitors Multiples
Sophia Genetics SA Competitors
Sophia Genetics SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
S
|
Sophia Genetics SA
NASDAQ:SOPH
|
323.5m USD | 5.2 | -4.1 | -3.2 | -2.9 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.7B USD | 13.8 | 62.2 | 62.1 | 66.8 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.7B AUD | 79.9 | 167.6 | 115.3 | 115.3 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7.4B USD | 11.9 | -350.6 | -185.9 | -172.7 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 4.8 | 24.1 | 12.5 | 14.1 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.5 | 32.5 | 21.7 | 23.1 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.5B SEK | 25.9 | 100 | -65.8 | -65.8 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -21.6 | 25.6 | 272.1 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.9B USD | 3.9 | -332.4 | 35.5 | -115.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
